General form of registration statement for all companies including face-amount certificate companies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
segment
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES            
Number of Reportable Segments | segment     1   1  
Fixed asset impairment charges     $ 0 $ 0 $ 0 $ 0
Uninsured cash balances   $ 33,814,000 $ 33,814,000   9,123,000  
Cancer treatment research award         2,000,000  
Reduction in research and development         $ 1,759,000  
Government Assistance, Income, Increase (Decrease), Statement of Income or Comprehensive Income [Extensible Enumeration] Costs and Expenses   Costs and Expenses      
Cancer treatment research award through the National Cancer Institute (NCI)            
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES            
Reduction in research and development     $ 602,000 $ 1,314,000   $ 697,000
Government Assistance Amount Cumulative   $ 2,000,000 $ 2,000,000      
Government Assistance Transaction Duration     3 years      
Grant received $ 1,980,000          
Minimum            
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES            
Property and equipment useful lives   3 years 3 years   3 years  
Share-based compensation expiration period   12 months 12 months   12 months  
Maximum            
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES            
Property and equipment useful lives   10 years 10 years   10 years  
Share-based compensation expiration period   3 years 3 years   3 years  
Leasehold improvements            
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES            
Property and equipment useful lives   64 months 64 months   64 months